Publications des scientifiques de l'IRD

Le Blay P., Rakotonirainy H., Lagier J. C., Raoult Didier, Puechal X., Pers Y. M. (2014). A severe Whipple disease with an immune reconstitution inflammatory syndrome : an additional case of thalidomide efficiency. Joint Bone Spine, 81 (3), p. 260-262. ISSN 1297-319X.

Titre du document
A severe Whipple disease with an immune reconstitution inflammatory syndrome : an additional case of thalidomide efficiency
Année de publication
2014
Type de document
Article référencé dans le Web of Science WOS:000336408100014
Auteurs
Le Blay P., Rakotonirainy H., Lagier J. C., Raoult Didier, Puechal X., Pers Y. M.
Source
Joint Bone Spine, 2014, 81 (3), p. 260-262 ISSN 1297-319X
We report the case of a 38-year-old man who presented with severe diarrhea, weight loss of 10 kg, ankles paresthesia and severe motor weakness in the left fibular nerve territory after introduction of azathioprine and corticosteroid for proteinuria. Coloscopy and gastroscopy revealed a typical aspect of Whipple disease (WD), associated with both positive PAS staining and specific immunohistochemistry. T. whipplei PCR results were positive in blood, faeces, saliva and duodenal biopsy specimens. Diagnosis of WD with systemic manifestations was retained and doxycycline plus hydroxychloroquine therapy were started. This treatment improved joint pain, and skin and intestinal symptoms. One month later, our patient presented with fever and an important inflammatory syndrome (CRP 150 mg/dL and 16.8 10(9)/L leukocytes), while no infection was found despite a thorough review. We concluded it was an immune reconstitution inflammatory syndrome (IRIS). Manifestations persisted despite increasing corticosteroids and thalidomide (200 mg/day) was introduced with good efficacy on these symptoms. WD may be revealed by non-specific symptoms such as weight loss or arthralgia, but also by many other misleading signs. Our observation illustrates the highly polymorphic clinical presentation of WD, and the diagnostic difficulties that may arise. This is also a new report of thalidomide effectiveness in IRIS in WD.
Plan de classement
Santé : généralités [050]
Identifiant IRD
PAR00011796
Contact